Biosafety Committee:
Overview

• Overview
• Application Review Process
• Policies and Guidance
• Biosafety Manual
• Training
• Incident Reporting
• Research Integrity Home

The University of Rhode Island Institutional Biosafety Committee (IBC) reviews and approves Biological Research protocols, where Biological Research is defined as any laboratory research or teaching activity involving:

• Recombinant or synthetic nucleic acid molecules (r/sDNA),
• Biological agents (i.e., viable infectious microorganisms (including prions) regardless of their pathogenicity to humans)
• Human or nonhuman primate materials
• Biological toxins subject to the National Select Agents Registry Program managed by the U.S. Departments of Health and Human Services (HHS) and Agriculture (USDA).

Prior to commencing Biological Research, investigators must submit a protocol for review by the IBC. The IBC is established to ensure that Biological Research is conducted safely, and that compliance is maintained with the following guidelines and regulations:

• NIH Guideline for Research Involving Recombinant DNA Molecules (NIH Guidelines)
• Occupational Safety and Health Administration–OSHA Bloodborne Pathogen Standard 1910.1030
• CDC-USDA Select Agent Regulations